• Publications
  • Influence
A Survey of Linear Parameter-Varying Control Applications Validated by Experiments or High-Fidelity Simulations
  • C. Hoffmann, H. Werner
  • Mathematics, Computer Science
  • IEEE Transactions on Control Systems Technology
  • 1 March 2015
TLDR
This paper provides a survey of results in linear parameter-varying (LPV) control that have been validated by experiments and/or high-fidelity simulations. Expand
  • 169
  • 7
Continuous Stereo Self-Calibration by Camera Parameter Tracking
TLDR
This paper presents a consistent framework for continuous stereo self-calibration of stereo cameras based on geometric error criteria. Expand
  • 101
  • 7
  • PDF
Impact of CYP2B6 983T>C polymorphism on non-nucleoside reverse transcriptase inhibitor plasma concentrations in HIV-infected patients.
OBJECTIVES The aim of this study was to investigate the frequency of CYP2B6 polymorphisms (according to ethnicity) and the influence of heterozygosity and homozygosity on plasma concentrations ofExpand
  • 167
  • 6
  • PDF
Combination of tenofovir and lamivudine versus tenofovir after lamivudine failure for therapy of hepatitis B in HIV-coinfection
Objective:At present sequential monotherapy for chronic hepatitis B with hepatitis B virus (HBV)-polymerase inhibitors is clinical practice. It is unknown to date whether combination therapy withExpand
  • 81
  • 6
Cytochrome P450 2B6 (CYP2B6) and constitutive androstane receptor (CAR) polymorphisms are associated with early discontinuation of efavirenz-containing regimens.
OBJECTIVES Cytochrome P450 2B6 (CYP2B6) is responsible for the metabolic clearance of efavirenz and single nucleotide polymorphisms (SNPs) in the CYP2B6 gene are associated with efavirenzExpand
  • 108
  • 6
  • PDF
Stage-adapted treatment of HIV-associated Hodgkin lymphoma: results of a prospective multicenter study.
PURPOSE Although the outcome of patients with HIV-related Hodgkin lymphoma (HIV-HL) has markedly improved since the introduction of combined antiretroviral therapy, standard therapy is still poorlyExpand
  • 72
  • 6
Effects of interleukin-2 plus highly active antiretroviral therapy on HIV-1 replication and proviral DNA (COSMIC trial)
BackgroundThe effect of interleukin-2 (IL-2) in combination with antiretroviral therapy on HIV-1 replication and reservoirs was investigated. MethodsIn a prospective, open-label trial, 56Expand
  • 124
  • 5
AIDS-related B-cell lymphoma (ARL): correlation of prognosis with differentiation profiles assessed by immunophenotyping.
This study was undertaken to analyze the differentiation profiles assessed by immunophenotyping in AIDS-related B-cell lymphoma (ARL) and their relation to the clinical course. Paraffin-embeddedExpand
  • 47
  • 5
  • PDF
Forty-eight-week efficacy and safety and early CNS tolerability of doravirine (MK-1439), a novel NNRTI, with TDF/FTC in ART-naive HIV-positive patients
Doravirine (DOR) is an investigational NNRTI (aka MK‐1439) that retains activity against common NNRTI‐resistant mutants. We have previously reported the Part 1 results from a two‐part, randomized,Expand
  • 50
  • 5
  • PDF
Clinical, Diagnostic, and Treatment Disparities between HIV-Infected and Non-HIV-Infected Immunocompromised Patients with Pneumocystis jirovecii Pneumonia
The substantial decline in the Pneumocystis jirovecii pneumonia (PCP) incidence in HIV-infected patients after the introduction of antiretroviral therapy (ART) in resource-rich settings and theExpand
  • 27
  • 5